The Explorer study: the first double-blind RCT to assess the efficacy of TLC-NOSF on DFUs.

D R Shanahan

Journal: Journal of wound care 2013;22(2):78-82

PMID: 23665662

Abstract

Urgo Medical recently announced the launch of the Explorer study, a large, Europe-wide, clinical study on the efficacy and tolerability of UrgoStart Contact, a lipidocolloid technology dressing impregnated with nano-oligosaccharide factor, in the treatment of diabetic foot ulceration. The number of patients, investigating centres and countries involved, as well as the length of treatment and patient follow-up, make this an ambitious, double-blind, randomised controlled trial.

DOI: 10.12968/jowc.2013.22.2.78

Link outs

Free resources

Medical:

https://medlineplus.gov/diabeticfoot.html

Other Literature Sources:

https://scite.ai/reports/23665662

Subscription / membership required

Full Text Sources:

https://www.magonlinelibrary.com/doi/10.12968/jowc...

MeSH Terms: Adult, Bandages, Hydrocolloid, Carboxymethylcellulose Sodium, Diabetic Foot, Europe, Humans, Multicenter Studies as Topic, Nanoparticles, Oligosaccharides, Randomized Controlled Trials as Topic, Research Design